Norbert W. Bischofberger, President & CEO at Kronos Bio, Inc. (KRON), bought 894,258 shares at $3.78 ($3.4M) on 2022-05-19, disclosed to the SEC on 2022-05-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.83 | 90,931 | $348K | 10.4% |
| 2 | $3.83 | 90,931 | $348K | 10.4% |
| 3 | $3.72 | 206,198 | $767K | 22.8% |
| 4 | $3.72 | 206,198 | $767K | 22.8% |
| 5 | $3.78 | 300,000 | $1.1M | 33.7% |
| Total | $3.76 avg | 894,258 |
| $3.4M |
| 100% |
| Filing → |
| KRON | BUY | 2023-11-17 | $2.7M | — | Filing → |
| KRON | BUY | 2021-12-08 | $347K | — | Filing → |
| KRON | BUY | 2020-10-16 | $1.8M | — | Filing → |